Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Acrivon Therapeutics, Inc. ( (ACRV) ) is now available.
On September 5, 2025, Acrivon Therapeutics updated its corporate presentation with new data showing strong synergy between its clinical candidates, ACR-368 and ACR-2316, and immune checkpoint inhibitors in syngeneic mouse models. This supports potential combinations with anti-PD(L)1 agents in frontline settings. The presentation also included updates on the ACR-368-201 trial and highlighted the capabilities of the AP3 platform in drug design and development, emphasizing its potential impact on the company’s operations and industry positioning.
The most recent analyst rating on (ACRV) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Acrivon Therapeutics, Inc. stock, see the ACRV Stock Forecast page.
Spark’s Take on ACRV Stock
According to Spark, TipRanks’ AI Analyst, ACRV is a Underperform.
Acrivon Therapeutics, Inc. faces major financial challenges, including no revenue, increasing losses, and negative cash flows, leading to a low overall score. The weak technical indicators further compound these concerns. However, recent corporate events, such as advancements in clinical programs and an extended cash runway, offer some optimism for future prospects. Investors should be cautious due to the company’s current financial instability.
To see Spark’s full report on ACRV stock, click here.
More about Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. is a next-generation precision medicine company focused on leveraging its Acrivon Predictive Precision Proteomics (AP3) platform to match disease-driving pathways with drug mechanisms. The company operates in the fields of oncology, fibrotic and inflammatory diseases, and autoimmune disorders, utilizing various therapeutic modalities such as small molecules and antibodies.
Average Trading Volume: 296,918
Technical Sentiment Signal: Hold
Current Market Cap: $40.89M
For a thorough assessment of ACRV stock, go to TipRanks’ Stock Analysis page.